Skip to content
  • Follow Us

CarboHyde

SUGAR IS LIFE

  • Home
  • About Us
  • Pipeline
  • Technology
  • Investors and Partnering
  • Career
  • CarboHyde News
  • CarboHyde’s Blog
  • Home
  • About Us
  • Pipeline
  • Technology
  • Investors and Partnering
  • Career
  • CarboHyde News
  • CarboHyde’s Blog

CarboHyde

SUGAR IS LIFE

  • Home
  • About Us
  • Pipeline
  • Technology
  • Investors and Partnering
  • Career
  • CarboHyde News
  • CarboHyde’s Blog

Tag: prostate cancer

Integrated method for urinary prostate specific antigen n-glycosylation profiling by capillary electrophoresis

Feb 1, 2023Tamas Sohajdadrug discoveryanalytical chemistry, cancer research, prostate cancer

Capillary electrophoresis-based (CE-based) comprehensive N-glycan analysis of urinary prostate-specific antigens for diagnosing PSA-related conditions.
Pannon Egyetem – University of Pannonia – Gabor Jarvas; Balazs Reider, Andras Guttman

A β-Cyclodextrin-Based Nanoparticle with Very High Transfection Efficiency Unveils siRNA-Activated TLR3 Responses in Human Prostate Cancer Cells

Nov 18, 2022Tamas Sohajdadrug deliverycancer research, gene therapy, prostate cancer

After reporting on intracellular protein delivery yesterday, today we share the latest news on RNA delivery to prostate cancer cells using cyclodextrin nanoparticles.
Universidad de Castilla-La Mancha, Instituto de Salud Carlos III, Universidad de Sevilla (Jose Manuel Garcia Fernandez, Valentin Ceña et al)

See the full article here

Categories

  • carbohydrates
  • drug delivery
  • drug development
  • drug discovery
  • Egyéb kategória
  • news
  • Today's cyclodextrin

Archive

  • March 2023 (36)
  • February 2023 (34)
  • January 2023 (31)
  • December 2022 (23)
  • November 2022 (33)
  • October 2022 (38)
  • September 2022 (9)

Latest posts

  • Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann–Pick Type C Using Quantitative Proteomics
  • A Guide to Your Desired Lipid-Asymmetric Vesicles
  • Grafting of Cyclodextrin to Theranostic Nanoparticles Improves Blood-Brain Barrier Model Crossing

Subscribe to our newsletter

alzheimers analytical chemistry anticancer atherosclerosis cancer research cancer treatment carbohyde cardiovascular chemistry cholesterol clinical trial covid19 cyclodextrin drug delivery formulation development gene therapy glycotime green chemistry infectious diseases monoclonal antibodies neurodegenerative diseases oncology research rare disease scientific advisory board synthesis

Developed by Shuttle Themes. Powered by WordPress.
  • Contact Us
  • LinkedIn
  • Twitter